Literature DB >> 509832

Silver polymethyl methacrylate antibacterial bone cement.

J A Spadaro, D A Webster, R O Becker.   

Abstract

An improved antibacterial bone cement was sought based on the addition of low concentrations of inorganic silver compounds to polymethyl methacrylate. Composites with AgCl, Ag-AgCl, Ag2O, Ag2SO4 and Ag3PO4 in concentrations of 0.05% to 1% by weight, were tested in vitro against bacterial cultures. All were effective, but Ag2SO4 was especially so, even after 7 weeks of incubation in normal saline. Compressive strength of the cement was not affected by these additions, except in the case of Ag2O. Biocompabibility tests in rabbit muscle for up to 12 weeks showed no significant difference between the Ag -PMM and plain PMM in tissue reactivity, both being minimal. These features, coupled with the broad spectrum of antibacterial activity and low allergic potential of silver, make Ag-PMM an attractive alternative to conventional organic antibiotic/bone cement composites.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 509832

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Experimental composite containing silicon dioxide-coated silver nanoparticles for orthodontic bonding: Antimicrobial activity and shear bond strength.

Authors:  Rogéria Christina de Oliveira Aguiar; Larissa Pereira Nunes; Eduardo Silva Batista; Marina Mariante Viana; Marcela Charantola Rodrigues; Bruno Bueno-Silva; Marina Guimarães Roscoe
Journal:  Dental Press J Orthod       Date:  2022-07-04

2.  Composition and properties of silver-containing calcium carbonate-calcium phosphate bone cement.

Authors:  Sylvaine Jacquart; Robin Siadous; Christel Henocq-Pigasse; Reine Bareille; Christine Roques; Christian Rey; Christèle Combes
Journal:  J Mater Sci Mater Med       Date:  2013-07-28       Impact factor: 3.896

3.  A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices.

Authors:  Alan B G Lansdown
Journal:  Adv Pharmacol Sci       Date:  2010-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.